A multi-platform diagnostic coverage architecture spanning infectious disease, physiology, microbiology, cardiac, and metabolic domains — toward 300–400 future test directions.
The analytical menu below represents the scope of conditions our platform is being engineered to address. It is a structured R&D roadmap — not an available test list. No test listed here is currently offered, validated, or available for clinical use. The menu will evolve as engineering development progresses and analytical verification milestones are reached.
The test-menu philosophy
BIQADX is being designed to support a broad future diagnostic landscape — toward approximately 300–400 future test and panel directions.
Each domain is mapped by platform fit, method suitability, carrier logic, and workflow practicality — not just by biomarker name. The test menu is a platform-coverage framework, not just a list.
Major clinical coverage branches
The strongest hospital and urgent-care territory in the portfolio — time-critical decisions at every step.
Aligns with decentralised care, compact cartridge execution, and high-throughput infectious screening.
A strong position in microbiology modernisation and phenotypic decision support.
Demonstrates premium photonic and near-patient acute-care capability.
Near-patient acute cardiovascular capability with premium photonic sensing.
Expands BIQADX beyond rapid triage into broader biochemical intelligence.
The high-ceiling future of pattern-based decentralised diagnostics.
Field-ready multiplex architecture with whole-blood front-end conditioning.
Multi-method analytical architecture
Clinical array ledger
Example directions across the platform — concept and R&D stage, illustrating coverage logic rather than validated assays.
| Analyte / Panel | Method | Platform Fit | Domain |
|---|---|---|---|
| CRP (C-Reactive Protein) | Immunoassay / Lateral Flow | Dr. POCT | Inflammation |
| 34-Pathogen ID Logic | Culture-Independent Multiplex Fluorescence | HELIX ONE | Infectious Disease |
| AST Panel (MIC Zones) | Electrochemical SPCE | BactoSnap | Microbiology |
| Culture ID (Bacterial) | AI Imaging — Well-plate OD | BactoSnap | Microbiology |
| Blood Gas & Electrolytes | Electrochemical ISE / Amperometric | VitalGas | Physiology |
| Lipid Panel (TC, LDL, HDL, TG) | Enzymatic Photometric | HELIX ONE | Metabolic |
| Renal Function Panel | Multi-Analyte Biochemical | HELIX ONE | Organ Function |
| Multi-Marker Protein Signature | Multi-Channel Fluorescence | EtherX-1 | Oncology-Adjacent |
| Respiratory Syndromic Panel | Electrochemical / Optical Multiplex | ViroSnap | Infectious Disease |
This page reflects the BIQADX innovation and platform-coverage vision across infectious disease, physiology, microbiology, cardiac, and metabolic domains. It should not be interpreted as blanket clinical validation or regulatory clearance. Concept and R&D stage throughout; analyte and panel entries are target directions, not demonstrated assays.